Dr. Collin Blakely is a medical oncologist who specializes in lung cancer. In addition to treating patients, he conducts research focused on understanding the cellular and molecular mechanisms underlying lung cancer resistance to targeted therapies. His goal is to translate laboratory findings into new treatments.
Blakely received his bachelor's degree in molecular and cellular biology from the University of Washington. He attended the Medical Scientist Training Program at the Perelman School of Medicine, earning both his medical and doctoral degrees. He completed his fellowship training in medical oncology at UCSF.
University of Pennsylvania Perelman School of Medicine, 2007
Hospital of the University of Pennsylvania, Internal Medicine, 2009
UCSF Medical Center, Medical Oncology, 2011
Internal Medicine, American Board of Internal Medicine
Medical Oncology, American Board of Internal Medicine